Trials / Completed
CompletedNCT04936724
FDA Cigarette Warning Labels: Eye Tracking Study
Evaluation of the New FDA Warning Labels: Does Highlighting Lesser Known Harms of Tobacco Use Increase Attention, Recall and Knowledge of Tobacco Harms for Young Adults?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the effect of cigarette pictorial warning label content (lesser-known vs well-known risks) on visual engagement, recall, and knowledge of tobacco use harms.
Detailed description
This laboratory-based study will aim to enroll 120 current cigarette users to complete a 1-day randomized, parallel design protocol. The participants will be randomized to one of two conditions, pictorial warning labels (PWLs) with well-known or lesser-known tobacco harms. After completing a baseline questionnaire, the participants will view 4 warning labels from the assigned group and complete a follow-up questionnaire. Eye-tracking will provide data on visual processing of the warning labels and the effect of these labels on knowledge, attitudes, and beliefs about smoking will be supplemented by self-report.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pictorial Warning Labels | Participants will be randomized to one of two conditions and will view 4 pictorial warning labels from the assigned group for an eye-tracking task. |
Timeline
- Start date
- 2020-12-22
- Primary completion
- 2021-11-19
- Completion
- 2021-11-19
- First posted
- 2021-06-23
- Last updated
- 2024-07-22
- Results posted
- 2024-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04936724. Inclusion in this directory is not an endorsement.